Wellington Management Group
PRME icon

Wellington Management Group’s Prime Medicine PRME Stock Holding History

Wellington Management Group’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
304,444
+26,324
+9% +$87.4K ﹤0.01% 1728
2026
Q1 		$968K Buy
278,120
+29,893
+12% +$114K ﹤0.01% 1682
2025
Q4 		$861K Buy
248,227
+42,902
+21% +$191K ﹤0.01% 1738
2025
Q3 		$1.14M Buy
+205,325
New +$834K ﹤0.01% 1753
2024
Q3 		– Sell
-37,646
Closed -$194K – 2005
2024
Q2 		$194K Buy
+37,646
New +$228K ﹤0.01% 1866

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Wellington Management Group's PRME Position: Q2 2026 in Review

Wellington Management Group increased its Prime Medicine (PRME) stake by 9.5% in Q2 2026, buying an estimated $87.4K and bringing the position to 304,444 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

Wellington Management Group first reported a position in PRME in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.14M in Q3 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Wellington Management Group held 304,444 shares of Prime Medicine worth $1.12M as of Q2 2026.
  • Wellington Management Group bought 26,324 Prime Medicine shares in Q2 2026, an estimated $87.4K.
  • Prime Medicine made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1728 holding.
  • Wellington Management Group first reported a position in Prime Medicine in Q2 2024 and has held it in 5 quarters since.
  • Wellington Management Group's Prime Medicine position peaked at $1.14M in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.